首页 > 最新文献

Acta Anaesthesiologica Scandinavica最新文献

英文 中文
Patient controlled epidural analgesia during labor: Protocol for a scoping review. 分娩过程中的患者自控硬膜外镇痛:范围界定审查协议。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-30 DOI: 10.1111/aas.14548
Magnus Grønbæk Henriksen, Nikoline Svensson, Ann Merete Møller

Background: Childbirth remains one of the most painful experiences for women. Patient-controlled epidural analgesia provides the women in labor with self-control and thereby a shorter time interval between onset of pain and administration of analgesia, thus potentially improving the childbirth experience. This scoping review aims to investigate PCEA during labor involving maternal satisfaction, risks of adverse effects and obstetric interventions by mapping the evidence and identifying gaps in the current evidence base.

Methods: The forthcoming review will adhere to the Preferred Reporting Items for Systematic reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) and the JBI methodology for scoping reviews. A systematic search will be carried out across major peer-reviewed databases and gray literature will be sought. All study types involving women in labor receiving PCEA will be eligible for inclusion. The extracted data will be charted regarding trial characteristics, population/participation characteristics, interventions, outcomes, and key findings.

Results: The results will be presented through relevant tables, figures, and graphs when appropriate. Alongside this, we present the data descriptively to explain how the results align with the objectives of the review.

Conclusion: PCEA offers women greater autonomy during childbirth, making it essential to examine its effects and potential risks. By mapping current evidence regarding PCEA, this review aims to identify knowledge gaps and provide insights to enhance maternal care and improve childbirth experiences.

背景:分娩仍然是妇女最痛苦的经历之一。患者自控硬膜外镇痛为产妇提供了自我控制能力,从而缩短了疼痛发作与镇痛给药之间的时间间隔,因此有可能改善分娩体验。本次范围界定综述旨在通过绘制证据图并找出当前证据库中的不足之处,调查分娩过程中的 PCEA 在产妇满意度、不良反应风险和产科干预方面的作用:即将开展的综述将遵守《系统综述和荟萃分析扩展至范围界定综述的首选报告项目》(PRISMA-ScR)和 JBI 范围界定综述方法。我们将在主要的同行评议数据库中进行系统检索,并寻找灰色文献。所有涉及接受 PCEA 的产妇的研究类型均可纳入。提取的数据将以图表形式列出试验特征、人群/参与特征、干预措施、结果和主要结论:结果:在适当的时候,我们将通过相关的表格、数字和图表来展示结果。同时,我们还将以描述性的方式呈现数据,以解释结果如何与综述目标相一致:PCEA 为妇女在分娩过程中提供了更大的自主权,因此研究其效果和潜在风险至关重要。本综述旨在通过对有关 PCEA 的现有证据进行分析,找出知识差距,为加强孕产妇护理和改善分娩体验提供真知灼见。
{"title":"Patient controlled epidural analgesia during labor: Protocol for a scoping review.","authors":"Magnus Grønbæk Henriksen, Nikoline Svensson, Ann Merete Møller","doi":"10.1111/aas.14548","DOIUrl":"10.1111/aas.14548","url":null,"abstract":"<p><strong>Background: </strong>Childbirth remains one of the most painful experiences for women. Patient-controlled epidural analgesia provides the women in labor with self-control and thereby a shorter time interval between onset of pain and administration of analgesia, thus potentially improving the childbirth experience. This scoping review aims to investigate PCEA during labor involving maternal satisfaction, risks of adverse effects and obstetric interventions by mapping the evidence and identifying gaps in the current evidence base.</p><p><strong>Methods: </strong>The forthcoming review will adhere to the Preferred Reporting Items for Systematic reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) and the JBI methodology for scoping reviews. A systematic search will be carried out across major peer-reviewed databases and gray literature will be sought. All study types involving women in labor receiving PCEA will be eligible for inclusion. The extracted data will be charted regarding trial characteristics, population/participation characteristics, interventions, outcomes, and key findings.</p><p><strong>Results: </strong>The results will be presented through relevant tables, figures, and graphs when appropriate. Alongside this, we present the data descriptively to explain how the results align with the objectives of the review.</p><p><strong>Conclusion: </strong>PCEA offers women greater autonomy during childbirth, making it essential to examine its effects and potential risks. By mapping current evidence regarding PCEA, this review aims to identify knowledge gaps and provide insights to enhance maternal care and improve childbirth experiences.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"e14548"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142542816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anterior quadratus lumborum blocks for postoperative pain treatment following intra-abdominal surgery: A systematic review with meta-analyses and trial sequential analyses. 用于腹腔内手术后疼痛治疗的腰前区阻滞:荟萃分析和试验序列分析的系统综述。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-18 DOI: 10.1111/aas.14526
Katrine Tanggaard, Caroline Gronlund, Martin V Nielsen, Kirstine la Cour, Casper D Tvarnø, Jens Børglum, Mathias Maagaard, Ole Mathiesen

Background: The anterior quadratus lumborum (QL) block may be used for postoperative pain management for intra-abdominal surgeries, but the evidence is uncertain. We aimed to investigate the benefit and harm of the anterior QL block compared to placebo/no block for intra-abdominal surgery.

Methods: We searched Medline, Embase, and CENTRAL for randomized controlled trials investigating anterior QL block for postoperative pain management for adult patients undergoing any intra-abdominal surgery. The two co-primary outcomes were cumulative 24-h opioid consumption and serious adverse events. We performed meta-analysis, trial sequential analysis (TSA), assessed the risk of bias, and present the certainty of evidence with the Grading of Recommendations, Assessment, Development and Evaluation approach.

Results: Thirty-five trials randomizing 2418 patients were included in the meta-analyses. Anterior QL block may reduce cumulative 24-h intravenous opioid consumption compared to placebo/no block (MD -10.42 mg, 96.7% CI -14.83 to -6.01, TSA-adjusted CI -17.03 to -3.82, p < .01). Two trials reported on SAEs. Anterior QL block may have little to no effect on the number of serious adverse events compared to placebo (RR 1.49, 96.7% CI 0.19 to 11.47, p = .68), but the evidence is very uncertain. All trial results were assessed as being high risk of bias.

Conclusions: The anterior QL block may reduce cumulative 24-h opioid consumption. Reported serious adverse events were few and the anterior QL block may have little to no effect on the number of SAEs, but the evidence was very uncertain.

背景:腰前肌阻滞(QL)可用于腹腔内手术的术后疼痛治疗,但相关证据尚不确定。我们的目的是研究腹腔内手术中前QL阻滞与安慰剂/无阻滞相比的利弊:我们在 Medline、Embase 和 CENTRAL 中检索了对接受任何腹腔内手术的成年患者进行 QL 前阻滞术后疼痛治疗的随机对照试验。两个共同主要结果是 24 小时阿片类药物累积用量和严重不良事件。我们进行了荟萃分析、试验序列分析(TSA),评估了偏倚风险,并采用建议、评估、发展和评价分级法对证据的确定性进行了评估:荟萃分析共纳入了35项试验,随机抽取了2418名患者。与安慰剂/无阻滞相比,QL前阻滞可减少24小时阿片类药物的累积静脉用量(MD -10.42 mg,96.7% CI -14.83 to -6.01,TSA调整后CI -17.03 to -3.82,P 结论:QL前阻滞可减少24小时阿片类药物的累积静脉用量:QL前阻滞可减少24小时阿片类药物的累积用量。报告的严重不良事件很少,QL前阻滞可能对SAE的数量几乎没有影响,但证据非常不确定。
{"title":"Anterior quadratus lumborum blocks for postoperative pain treatment following intra-abdominal surgery: A systematic review with meta-analyses and trial sequential analyses.","authors":"Katrine Tanggaard, Caroline Gronlund, Martin V Nielsen, Kirstine la Cour, Casper D Tvarnø, Jens Børglum, Mathias Maagaard, Ole Mathiesen","doi":"10.1111/aas.14526","DOIUrl":"10.1111/aas.14526","url":null,"abstract":"<p><strong>Background: </strong>The anterior quadratus lumborum (QL) block may be used for postoperative pain management for intra-abdominal surgeries, but the evidence is uncertain. We aimed to investigate the benefit and harm of the anterior QL block compared to placebo/no block for intra-abdominal surgery.</p><p><strong>Methods: </strong>We searched Medline, Embase, and CENTRAL for randomized controlled trials investigating anterior QL block for postoperative pain management for adult patients undergoing any intra-abdominal surgery. The two co-primary outcomes were cumulative 24-h opioid consumption and serious adverse events. We performed meta-analysis, trial sequential analysis (TSA), assessed the risk of bias, and present the certainty of evidence with the Grading of Recommendations, Assessment, Development and Evaluation approach.</p><p><strong>Results: </strong>Thirty-five trials randomizing 2418 patients were included in the meta-analyses. Anterior QL block may reduce cumulative 24-h intravenous opioid consumption compared to placebo/no block (MD -10.42 mg, 96.7% CI -14.83 to -6.01, TSA-adjusted CI -17.03 to -3.82, p < .01). Two trials reported on SAEs. Anterior QL block may have little to no effect on the number of serious adverse events compared to placebo (RR 1.49, 96.7% CI 0.19 to 11.47, p = .68), but the evidence is very uncertain. All trial results were assessed as being high risk of bias.</p><p><strong>Conclusions: </strong>The anterior QL block may reduce cumulative 24-h opioid consumption. Reported serious adverse events were few and the anterior QL block may have little to no effect on the number of SAEs, but the evidence was very uncertain.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"e14526"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142455396","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Veno-venous extracorporeal membrane oxygenation for severe COVID-19 associated acute respiratory distress syndrome: A retrospective, nationwide, Danish cohort study. 静脉体外膜氧合治疗严重 COVID-19 相关急性呼吸窘迫综合征:一项回顾性、全国性、丹麦队列研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2025-01-01 Epub Date: 2024-10-22 DOI: 10.1111/aas.14522
Finn Møller Pedersen, Lars Grønlykke, Camilla Tofte Eschen, Janne Adelsten, Søren Aalbæk Madsen, Marc Sørensen, Jakob Gjedsted, Peter Hasse Møller-Sørensen, Jonas Nielsen, Steffen Christensen, Dorthe Viemose Nielsen, Vibeke Lind Jørgensen

Background: Severe acute respiratory syndrome (ARDS) may require veno-venous extracorporeal membrane oxygenation (V-V ECMO). The aim of this study was to provide data on patient selection and outcome in a nationwide cohort study of patients with COVID-19 associated ARDS supported with V-V ECMO.

Methods: We identified all patients with COVID-19, who were supported with V-V ECMO in Denmark from March 10, 2020, to December 31, 2021, and retrieved data on patients who were referred to- and accepted for ECMO, demographics, outcome data, and complications. Risk factors for mortality were analysed using multivariate Cox regression analysis.

Results: During the study period, 1836 patients were admitted to Danish intensive care units (ICUs). In the same period, there were 197 enquiries for ECMO of whom 118 patients were considered eligible. Overall, 71 patients were cannulated for ECMO; three patients were cannulated for veno-arterial extracorporeal membrane oxygenation (V-A ECMO) due to right sided heart failure and 68 patients were cannulated for V-V ECMO. Two patients accepted for V-V ECMO died during cannulation. The median age was 55 years (IQR 45-60) and 66% were males. The median duration of ECMO support was 13 days (IQR 7-21), mechanical ventilation median 26 days (IQR 14-42), ICU stay median 34 days (IQR 17-46), and length of hospital stay median 41 days (IQR 25-56). Ninety-day mortality was 43%. Age of 60 years or more was associated with an increased risk of mortality. Pre-existing hypertension was associated with a decreased risk of mortality.

Conclusion: A nationwide, Danish cohort study of 68 COVID-19 patients supported with V-V ECMO, showed a 90-day survival of 43%, which is in accordance with reports from comparable cohorts. Age of 60 years or more was associated with an increased risk of mortality. Pre-existing hypertension was associated with a decreased risk of mortality.

背景:严重急性呼吸综合征(ARDS)可能需要静脉-静脉体外膜氧合(V-V ECMO)。本研究的目的是在一项全国性队列研究中提供有关患者选择和预后的数据,研究对象是接受 V-V ECMO 支持的 COVID-19 相关 ARDS 患者:我们确定了 2020 年 3 月 10 日至 2021 年 12 月 31 日期间在丹麦接受 V-V ECMO 支持的所有 COVID-19 患者,并检索了转诊和接受 ECMO 患者的数据、人口统计学、结果数据和并发症。采用多变量考克斯回归分析法对死亡率的风险因素进行了分析:研究期间,丹麦重症监护病房(ICU)共收治了 1836 名患者。同期,有 197 人咨询 ECMO 事宜,其中 118 人符合条件。总体而言,71 名患者接受了 ECMO 插管;3 名患者因右侧心衰接受了静脉-动脉体外膜氧合(V-A ECMO)插管,68 名患者接受了 V-V ECMO 插管。两名接受 V-V ECMO 的患者在插管期间死亡。中位年龄为 55 岁(IQR 45-60),66% 为男性。ECMO 支持时间中位数为 13 天(IQR 7-21),机械通气时间中位数为 26 天(IQR 14-42),重症监护室住院时间中位数为 34 天(IQR 17-46),住院时间中位数为 41 天(IQR 25-56)。九十天死亡率为 43%。年龄在60岁或以上与死亡风险增加有关。原有高血压与死亡风险降低有关:一项对 68 名接受 V-V ECMO 支持的 COVID-19 患者进行的全国性丹麦队列研究显示,90 天存活率为 43%,这与同类队列的报告一致。年龄在 60 岁或以上与死亡风险增加有关。原有高血压与死亡风险降低有关。
{"title":"Veno-venous extracorporeal membrane oxygenation for severe COVID-19 associated acute respiratory distress syndrome: A retrospective, nationwide, Danish cohort study.","authors":"Finn Møller Pedersen, Lars Grønlykke, Camilla Tofte Eschen, Janne Adelsten, Søren Aalbæk Madsen, Marc Sørensen, Jakob Gjedsted, Peter Hasse Møller-Sørensen, Jonas Nielsen, Steffen Christensen, Dorthe Viemose Nielsen, Vibeke Lind Jørgensen","doi":"10.1111/aas.14522","DOIUrl":"10.1111/aas.14522","url":null,"abstract":"<p><strong>Background: </strong>Severe acute respiratory syndrome (ARDS) may require veno-venous extracorporeal membrane oxygenation (V-V ECMO). The aim of this study was to provide data on patient selection and outcome in a nationwide cohort study of patients with COVID-19 associated ARDS supported with V-V ECMO.</p><p><strong>Methods: </strong>We identified all patients with COVID-19, who were supported with V-V ECMO in Denmark from March 10, 2020, to December 31, 2021, and retrieved data on patients who were referred to- and accepted for ECMO, demographics, outcome data, and complications. Risk factors for mortality were analysed using multivariate Cox regression analysis.</p><p><strong>Results: </strong>During the study period, 1836 patients were admitted to Danish intensive care units (ICUs). In the same period, there were 197 enquiries for ECMO of whom 118 patients were considered eligible. Overall, 71 patients were cannulated for ECMO; three patients were cannulated for veno-arterial extracorporeal membrane oxygenation (V-A ECMO) due to right sided heart failure and 68 patients were cannulated for V-V ECMO. Two patients accepted for V-V ECMO died during cannulation. The median age was 55 years (IQR 45-60) and 66% were males. The median duration of ECMO support was 13 days (IQR 7-21), mechanical ventilation median 26 days (IQR 14-42), ICU stay median 34 days (IQR 17-46), and length of hospital stay median 41 days (IQR 25-56). Ninety-day mortality was 43%. Age of 60 years or more was associated with an increased risk of mortality. Pre-existing hypertension was associated with a decreased risk of mortality.</p><p><strong>Conclusion: </strong>A nationwide, Danish cohort study of 68 COVID-19 patients supported with V-V ECMO, showed a 90-day survival of 43%, which is in accordance with reports from comparable cohorts. Age of 60 years or more was associated with an increased risk of mortality. Pre-existing hypertension was associated with a decreased risk of mortality.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"e14522"},"PeriodicalIF":1.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142492656","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lack of correlation between biomarkers and acute kidney injury after pediatric cardiac surgery with cardiopulmonary bypass: Should be look for something else? 使用心肺旁路的小儿心脏手术后,生物标志物与急性肾损伤之间缺乏相关性:是否应该寻找其他原因?
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-09-23 DOI: 10.1111/aas.14520
Guillermo Lema
{"title":"Lack of correlation between biomarkers and acute kidney injury after pediatric cardiac surgery with cardiopulmonary bypass: Should be look for something else?","authors":"Guillermo Lema","doi":"10.1111/aas.14520","DOIUrl":"10.1111/aas.14520","url":null,"abstract":"","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"1607"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142306932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhaled analgesics for the treatment of prehospital acute pain-A systematic review. 治疗院前急性疼痛的吸入镇痛剂--系统综述。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-09-26 DOI: 10.1111/aas.14527
Per Kristian Hyldmo, Marius Rehn, Kristian Dahl Friesgaard, Leif Rognås, Lasse Raatiniemi, Jouni Kurola, Robert Larsen, Poul Kongstad, Mårten Sandberg, Vidar Magnusson, Gunn Elisabeth Vist

Background: Many prehospital emergency patients receive suboptimal treatment for their moderate to severe pain. Various factors may contribute. We aim to systematically review literature pertaining to prehospital emergency adult patients with acute pain and the pain-reducing effects, adverse events (AEs), and safety issues associated with inhaled analgetic agents compared with other prehospital analgesic agents.

Methods: As part of an initiative from the Scandinavian Society of Anaesthesia and Intensive Care Medicine, we conducted a systematic review (PROSPERO CRD42018114399), applying the PRISMA guidelines, Grading of Recommendations Assessment, Development, and Evaluation (GRADE), and Cochrane methods, searching the Cochrane Library, Epistemonikos, Centre for Reviews and Dissemination, PubMed, and EMBASE databases (updated March 2024). Inclusion criteria were the use of inhaled analgesic agents in adult patients with acute pain in the prehospital emergency care setting. All steps were performed by minimum of two individual researchers. The primary outcome was pain reduction; secondary outcomes were speed of onset, duration of effect, and relevant AEs.

Results: We included seven studies (56,535 patients in total) that compared inhaled agents (methoxyflurane [MF] and nitrous oxide [N2O]) to other drugs or placebo. Study designs were randomized controlled trial (1; n = 60), randomized non-blinded study (1; n = 343), and randomized open-label study (1; n = 270). The remaining were prospective or retrospective observational studies. The evidence according to GRADE was of low or very low quality. No combined meta-analysis was possible. N2O may reduce pain compared to placebo, but not compared to intravenous (IV) paracetamol, and may be less effective compared to morphine and MF. MF may reduce pain compared to paracetamol, ketoprofen, tramadol, and fentanyl. Both agents may be associated with marked but primarily mild AEs.

Conclusion: We found low-quality evidence suggesting that both MF and N2O are safe and may have a role in the management of pain in the prehospital setting. There is low-quality evidence to support MF as a short-acting single analgesic or as a bridge to IV access and the administration of other analgesics. There may be occupational health issues regarding the prehospital use of N2O.

背景:许多院前急诊病人在中度至重度疼痛方面所接受的治疗效果并不理想。这可能是多种因素造成的。我们旨在系统回顾有关院前急救成人急性疼痛患者的文献,以及与其他院前镇痛剂相比,吸入镇痛剂的镇痛效果、不良事件(AEs)和安全性问题:作为斯堪的纳维亚麻醉和重症监护医学会倡议的一部分,我们应用 PRISMA 指南、建议评估、开发和评价分级 (GRADE) 以及 Cochrane 方法,检索了 Cochrane 图书馆、Epistemonikos、Centre for Reviews and Dissemination、PubMed 和 EMBASE 数据库(2024 年 3 月更新),进行了一项系统性综述(PROSPERO CRD42018114399)。纳入标准是在院前急救环境中对急性疼痛的成年患者使用吸入式镇痛剂。所有步骤至少由两名研究人员共同完成。主要结果是疼痛减轻;次要结果是起效速度、疗效持续时间和相关的 AEs:我们纳入了七项研究(共 56,535 名患者),这些研究将吸入剂(甲氧基氟烷 [MF] 和氧化亚氮 [N2O])与其他药物或安慰剂进行了比较。研究设计包括随机对照试验(1;n = 60)、随机非盲研究(1;n = 343)和随机开放标签研究(1;n = 270)。其余为前瞻性或回顾性观察研究。根据 GRADE,这些证据的质量较低或很低。无法进行综合荟萃分析。与安慰剂相比,一氧化二氮可减轻疼痛,但与静脉注射扑热息痛相比,一氧化二氮不能减轻疼痛。与扑热息痛、酮洛芬、曲马多和芬太尼相比,吗啡可减轻疼痛。两种药物都可能伴有明显但主要是轻微的不良反应:我们发现低质量的证据表明,MF 和 N2O 都是安全的,可在院前疼痛治疗中发挥作用。有低质量的证据支持将 MF 用作短效单一镇痛药或作为静脉注射和使用其他镇痛药的桥梁。院前使用一氧化二氮可能存在职业健康问题。
{"title":"Inhaled analgesics for the treatment of prehospital acute pain-A systematic review.","authors":"Per Kristian Hyldmo, Marius Rehn, Kristian Dahl Friesgaard, Leif Rognås, Lasse Raatiniemi, Jouni Kurola, Robert Larsen, Poul Kongstad, Mårten Sandberg, Vidar Magnusson, Gunn Elisabeth Vist","doi":"10.1111/aas.14527","DOIUrl":"10.1111/aas.14527","url":null,"abstract":"<p><strong>Background: </strong>Many prehospital emergency patients receive suboptimal treatment for their moderate to severe pain. Various factors may contribute. We aim to systematically review literature pertaining to prehospital emergency adult patients with acute pain and the pain-reducing effects, adverse events (AEs), and safety issues associated with inhaled analgetic agents compared with other prehospital analgesic agents.</p><p><strong>Methods: </strong>As part of an initiative from the Scandinavian Society of Anaesthesia and Intensive Care Medicine, we conducted a systematic review (PROSPERO CRD42018114399), applying the PRISMA guidelines, Grading of Recommendations Assessment, Development, and Evaluation (GRADE), and Cochrane methods, searching the Cochrane Library, Epistemonikos, Centre for Reviews and Dissemination, PubMed, and EMBASE databases (updated March 2024). Inclusion criteria were the use of inhaled analgesic agents in adult patients with acute pain in the prehospital emergency care setting. All steps were performed by minimum of two individual researchers. The primary outcome was pain reduction; secondary outcomes were speed of onset, duration of effect, and relevant AEs.</p><p><strong>Results: </strong>We included seven studies (56,535 patients in total) that compared inhaled agents (methoxyflurane [MF] and nitrous oxide [N<sub>2</sub>O]) to other drugs or placebo. Study designs were randomized controlled trial (1; n = 60), randomized non-blinded study (1; n = 343), and randomized open-label study (1; n = 270). The remaining were prospective or retrospective observational studies. The evidence according to GRADE was of low or very low quality. No combined meta-analysis was possible. N<sub>2</sub>O may reduce pain compared to placebo, but not compared to intravenous (IV) paracetamol, and may be less effective compared to morphine and MF. MF may reduce pain compared to paracetamol, ketoprofen, tramadol, and fentanyl. Both agents may be associated with marked but primarily mild AEs.</p><p><strong>Conclusion: </strong>We found low-quality evidence suggesting that both MF and N<sub>2</sub>O are safe and may have a role in the management of pain in the prehospital setting. There is low-quality evidence to support MF as a short-acting single analgesic or as a bridge to IV access and the administration of other analgesics. There may be occupational health issues regarding the prehospital use of N<sub>2</sub>O.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"1306-1318"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142338978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypernatremia in hospitalised adult patients: A protocol for a scoping review. 住院成人患者的高钠血症:范围界定审查方案。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-03 DOI: 10.1111/aas.14491
Sine Wichmann, Rasmus Rønhøj, Karen L Ellekjær, Morten Hylander Møller, Morten H Bestle

Background: Hypernatremia is a common electrolyte disturbance in hospitalised patients associated with adverse outcomes. The aetiology is diverse but often related to fluid therapy and sodium-containing medicaments. We aim to outline the evidence base on hypernatremia in adult hospitalised patients.

Methods: We will conduct a scoping review and adhere to the preferred reporting items for systematic and meta-analysis extension for scoping reviews (PRISMA-ScR). We will systematically search the Cochrane Library, Medline, Pubmed, and Embase from inception with no limitations to language, and include all study designs. We will use the population, exposure, comparator, and outcome-based approach to define eligibility criteria. The population: adult hospitalised patients; exposure: hypernatremia; comparator: no hypernatremia or all types of treatments of hypernatremia; and outcomes: all reported outcomes. Two authors will independently screen and select studies followed by full-text assessment and data extraction in duplicate. All outcome measures will be reported, and descriptive analyses will be performed. The certainty of evidence will be assessed according to an adapted grading of recommendations assessment, development, and evaluation (GRADE) approach.

Discussion: This scoping review will provide an overview of the current evidence regarding the incidence of hypernatremia, treatment modalities, and outcomes reported for hospitalised adult patients with hypernatremia.

背景:高钠血症是住院病人常见的电解质紊乱,与不良预后有关。病因多种多样,但通常与液体疗法和含钠药物有关。我们旨在概述成人住院患者高钠血症的证据基础:我们将进行范围界定综述,并遵守范围界定综述的系统和荟萃分析扩展首选报告项目(PRISMA-ScR)。我们将从一开始就在 Cochrane 图书馆、Medline、Pubmed 和 Embase 中进行系统检索,语言不限,并包括所有研究设计。我们将采用基于人群、暴露、比较者和结果的方法来定义资格标准。研究对象:成年住院患者;暴露:高钠血症;参照物:无高钠血症或所有类型的高钠血症治疗方法;结果:所有已报告的结果。两位作者将独立筛选研究,然后进行全文评估和数据提取,一式两份。将报告所有结果测量指标,并进行描述性分析。证据的确定性将根据经过调整的建议评估、发展和评价分级(GRADE)方法进行评估:本范围界定综述将概述有关高钠血症发病率、治疗方式以及高钠血症住院成人患者治疗结果的现有证据。
{"title":"Hypernatremia in hospitalised adult patients: A protocol for a scoping review.","authors":"Sine Wichmann, Rasmus Rønhøj, Karen L Ellekjær, Morten Hylander Møller, Morten H Bestle","doi":"10.1111/aas.14491","DOIUrl":"10.1111/aas.14491","url":null,"abstract":"<p><strong>Background: </strong>Hypernatremia is a common electrolyte disturbance in hospitalised patients associated with adverse outcomes. The aetiology is diverse but often related to fluid therapy and sodium-containing medicaments. We aim to outline the evidence base on hypernatremia in adult hospitalised patients.</p><p><strong>Methods: </strong>We will conduct a scoping review and adhere to the preferred reporting items for systematic and meta-analysis extension for scoping reviews (PRISMA-ScR). We will systematically search the Cochrane Library, Medline, Pubmed, and Embase from inception with no limitations to language, and include all study designs. We will use the population, exposure, comparator, and outcome-based approach to define eligibility criteria. The population: adult hospitalised patients; exposure: hypernatremia; comparator: no hypernatremia or all types of treatments of hypernatremia; and outcomes: all reported outcomes. Two authors will independently screen and select studies followed by full-text assessment and data extraction in duplicate. All outcome measures will be reported, and descriptive analyses will be performed. The certainty of evidence will be assessed according to an adapted grading of recommendations assessment, development, and evaluation (GRADE) approach.</p><p><strong>Discussion: </strong>This scoping review will provide an overview of the current evidence regarding the incidence of hypernatremia, treatment modalities, and outcomes reported for hospitalised adult patients with hypernatremia.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"1541-1543"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141496811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delirium diagnostic tools in the postoperative setting: A scoping review protocol. 术后谵妄诊断工具:范围审查协议。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-08 DOI: 10.1111/aas.14486
Charlotte Levy Hansen, Thordis Thomsen, Aske Tøgern, Ann Merete Møller, Morten Vester-Andersen, Søren Overgaard, Nicolai Bang Foss, Daniel Hägi-Pedersen

Background: Delirium is an acute and fluctuating disturbance in attention, awareness, and cognition, commonly observed in hospital settings, particularly among older adults, critically ill and surgical patients. Delirium poses significant challenges in patient care, leading to increased morbidity, mortality, prolonged hospital stays, and functional decline.

Aim: The aim of this review is to map existing evidence on delirium diagnostic tools suitable for use in patients treated surgically due to hip fracture, to inform clinical practice and enhance patient care protocols in the postoperative setting.

Method: We will conduct a scoping review on delirium diagnostic tools used for adult patients in the postoperative setting according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). Eligibility criteria encompass all languages, publications dates, and study designs, with exception of case-reports. We will systematically search multiple databases and include unpublished trials, ensuring a comprehensive review based on a predefined protocol.

Results: Results will be presented descriptively, with supplementary tables and graphs. Studies will be grouped by design, surgical specialties, and diagnostic tools to identify potential variations.

Conclusion: This scoping review will provide an overview of existing delirium diagnostic tools used in the postoperative setting and highlight knowledge-gaps to support future research. Due to the large number of patients affected by postoperative delirium, evidence mapping is much needed to facilitate evidence-based practice.

背景:谵妄是一种急性、波动性的注意力、意识和认知障碍,常见于医院环境中,尤其是老年人、危重病人和手术病人。谵妄给患者护理带来了巨大挑战,导致发病率、死亡率、住院时间延长和功能衰退的增加。目的:本综述旨在绘制适用于因髋部骨折接受手术治疗的患者的谵妄诊断工具的现有证据图,为临床实践提供参考,并加强术后患者护理方案:我们将根据 "系统综述和荟萃分析首选报告项目"(Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews,PRISMA-ScR)对术后成年患者使用的谵妄诊断工具进行范围界定综述。资格标准包括所有语言、发表日期和研究设计,病例报告除外。我们将系统地搜索多个数据库,并纳入未发表的试验,确保根据预定方案进行全面综述:结果:结果将以描述性方式呈现,并配有补充表格和图表。研究将按设计、外科专科和诊断工具分组,以确定潜在的差异:本范围综述将概述术后环境中使用的现有谵妄诊断工具,并强调知识差距以支持未来的研究。由于受术后谵妄影响的患者人数众多,因此亟需证据图谱来促进循证实践。
{"title":"Delirium diagnostic tools in the postoperative setting: A scoping review protocol.","authors":"Charlotte Levy Hansen, Thordis Thomsen, Aske Tøgern, Ann Merete Møller, Morten Vester-Andersen, Søren Overgaard, Nicolai Bang Foss, Daniel Hägi-Pedersen","doi":"10.1111/aas.14486","DOIUrl":"10.1111/aas.14486","url":null,"abstract":"<p><strong>Background: </strong>Delirium is an acute and fluctuating disturbance in attention, awareness, and cognition, commonly observed in hospital settings, particularly among older adults, critically ill and surgical patients. Delirium poses significant challenges in patient care, leading to increased morbidity, mortality, prolonged hospital stays, and functional decline.</p><p><strong>Aim: </strong>The aim of this review is to map existing evidence on delirium diagnostic tools suitable for use in patients treated surgically due to hip fracture, to inform clinical practice and enhance patient care protocols in the postoperative setting.</p><p><strong>Method: </strong>We will conduct a scoping review on delirium diagnostic tools used for adult patients in the postoperative setting according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). Eligibility criteria encompass all languages, publications dates, and study designs, with exception of case-reports. We will systematically search multiple databases and include unpublished trials, ensuring a comprehensive review based on a predefined protocol.</p><p><strong>Results: </strong>Results will be presented descriptively, with supplementary tables and graphs. Studies will be grouped by design, surgical specialties, and diagnostic tools to identify potential variations.</p><p><strong>Conclusion: </strong>This scoping review will provide an overview of existing delirium diagnostic tools used in the postoperative setting and highlight knowledge-gaps to support future research. Due to the large number of patients affected by postoperative delirium, evidence mapping is much needed to facilitate evidence-based practice.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"1528-1531"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141557722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Small-volume blood sample collection tubes in adult intensive care units: A rapid practice guideline. 成人重症监护病房的小容量血液样本采集管:快速操作指南。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-21 DOI: 10.1111/aas.14497
Jeannie Callum, Zbignew Putowski, Waleed Alhazzani, Emilie Belley-Cote, Morten Hylander Møller, Nicola Curry, Zainab Al Duhailib, Mark Fung, Louise Giocobbo, Anders Granholm, Vernon Louw, Patrick Maybohm, Marcella Muller, Nathan Nielsen, Curtis Oleschuk, Sheharyar Raza, Elizabeth Scruth, Deborah Siegal, Simon J Stanworth, Alexander P J Vlaar, Micheline White, Simon Oczkowski

Background: This Intensive Care Medicine Rapid Practice Guideline (ICM-RPG) provides an evidence-based recommendation to address the question: in adult patients in intensive care units (ICUs), should we use small-volume or conventional blood collection tubes?

Methods: We included 23 panelists in 8 countries and assessed and managed financial and intellectual conflicts of interest. Methodological support was provided by the Guidelines in Intensive Care, Development, and Evaluation (GUIDE) group. We conducted a systematic review, including evidence from observational and randomized studies. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach, we evaluated the certainty of evidence and developed recommendations using the Evidence-to-Decision framework.

Results: We identified 8 studies (1 cluster and 2 patient-level randomized trials; 5 observational studies) comparing small-volume to conventional tubes. We had high certainty evidence that small-volume tubes reduce daily and cumulative blood sampling volume; and moderate certainty evidence that they reduce the risk of transfusion and mean number of red blood cell units transfused, but these estimates were limited by imprecision. We had high certainty that small-volume tubes have a similar rate of specimens with insufficient quantity. The panel considered that the desirable effects of small-volume tubes outweigh the undesirable effects, are less wasteful of resources, and are feasible, as demonstrated by successful implementation across multiple countries, although there are upfront implementation costs to validate small-volume tubes on laboratory instrumentation.

Conclusion: This ICM-RPG panel made a strong recommendation for the use of small-volume sample collection tubes in adult ICUs based on overall moderate certainty evidence.

背景:本《重症监护医学快速实践指南》(ICM-RPG)针对以下问题提供了循证建议:对于重症监护病房(ICU)的成人患者,我们应该使用小容量采血管还是常规采血管?我们纳入了来自 8 个国家的 23 位专家组成员,并评估和管理了经济和智力利益冲突。重症监护指南、开发和评估(GUIDE)小组提供了方法学支持。我们进行了系统性回顾,包括观察性研究和随机研究的证据。我们采用建议、评估、发展和评价分级法(GRADE)评估了证据的确定性,并利用 "从证据到决定 "框架提出了建议:我们确定了 8 项比较小容量输液管和传统输液管的研究(1 项群组试验和 2 项患者水平随机试验;5 项观察性研究)。我们有高度确定性的证据表明,小容量输血管减少了每日和累计采血量;有中度确定性的证据表明,小容量输血管降低了输血风险和平均输注红细胞单位数,但这些估计值因不精确而受到限制。我们高度确定小容量采血管具有相似的标本数量不足率。专家小组认为,小容量试管的理想效果大于不理想效果,减少了资源浪费,而且可行,多个国家的成功实施就证明了这一点,尽管在实验室仪器上验证小容量试管需要前期实施成本:ICM-RPG小组根据总体中等确定性证据,强烈建议在成人重症监护病房使用小容量样本采集管。
{"title":"Small-volume blood sample collection tubes in adult intensive care units: A rapid practice guideline.","authors":"Jeannie Callum, Zbignew Putowski, Waleed Alhazzani, Emilie Belley-Cote, Morten Hylander Møller, Nicola Curry, Zainab Al Duhailib, Mark Fung, Louise Giocobbo, Anders Granholm, Vernon Louw, Patrick Maybohm, Marcella Muller, Nathan Nielsen, Curtis Oleschuk, Sheharyar Raza, Elizabeth Scruth, Deborah Siegal, Simon J Stanworth, Alexander P J Vlaar, Micheline White, Simon Oczkowski","doi":"10.1111/aas.14497","DOIUrl":"10.1111/aas.14497","url":null,"abstract":"<p><strong>Background: </strong>This Intensive Care Medicine Rapid Practice Guideline (ICM-RPG) provides an evidence-based recommendation to address the question: in adult patients in intensive care units (ICUs), should we use small-volume or conventional blood collection tubes?</p><p><strong>Methods: </strong>We included 23 panelists in 8 countries and assessed and managed financial and intellectual conflicts of interest. Methodological support was provided by the Guidelines in Intensive Care, Development, and Evaluation (GUIDE) group. We conducted a systematic review, including evidence from observational and randomized studies. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach, we evaluated the certainty of evidence and developed recommendations using the Evidence-to-Decision framework.</p><p><strong>Results: </strong>We identified 8 studies (1 cluster and 2 patient-level randomized trials; 5 observational studies) comparing small-volume to conventional tubes. We had high certainty evidence that small-volume tubes reduce daily and cumulative blood sampling volume; and moderate certainty evidence that they reduce the risk of transfusion and mean number of red blood cell units transfused, but these estimates were limited by imprecision. We had high certainty that small-volume tubes have a similar rate of specimens with insufficient quantity. The panel considered that the desirable effects of small-volume tubes outweigh the undesirable effects, are less wasteful of resources, and are feasible, as demonstrated by successful implementation across multiple countries, although there are upfront implementation costs to validate small-volume tubes on laboratory instrumentation.</p><p><strong>Conclusion: </strong>This ICM-RPG panel made a strong recommendation for the use of small-volume sample collection tubes in adult ICUs based on overall moderate certainty evidence.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"1319-1326"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141733224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Opioids and personalized analgesia in the perioperative setting: A protocol for five systematic reviews. 围术期阿片类药物和个性化镇痛:五项系统性综述方案。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-06 DOI: 10.1111/aas.14508
Anders Peder Højer Karlsen, Pernille Bjersand Sunde, Markus Harboe Olsen, Jens Laigaard, Caroline Folkersen, Trang Xuan Minh Tran, Ida Houtved Rasmussen, Selma Kjartansdóttir, Atena Saito, Michael Asger Andersen, Mathias Maagaard, Nicholas Papadomanolakis-Pakis, Kim Dalhoff, Lone Nikolajsen, Troels Haxholdt Lunn, Christian Sylvest Meyhoff, Janus Christian Jakobsen, Ole Mathiesen

Background: Treatment with opioids is a mainstay in perioperative pain management. While the leading treatment paradigm has been procedure-specific pain management, efforts regarding personalized pain treatment are increasing. The OPI•AID project aims to develop personalized algorithms for perioperative pain management, taking demographic, surgical, and anaesthesiologic factors into account. We will undertake five parallel reviews to illuminate current evidence on different aspects of individual responses to perioperative opioid treatment.

Methods: Inclusion of adult populations in English-written studies. Review-specific searches are developed for the following databases: CENTRAL, MEDLINE, Embase, clinicaltrials.gov, and clinicaltrial.eu. Two authors will independently screen citations, extract data, and assess the risks of bias in each review (QUIPS, PROBAST and RoB2, as relevant).

Conclusion: These reviews will evaluate various aspects of perioperative opioid treatment, including individualized treatment strategies, selection of specific opioids, and individual patient responses. These will guide future development of a personalized perioperative opioid treatment algorithm (OPI•AID) that will be validated and tested clinically against standard of care.

背景:阿片类药物治疗是围手术期疼痛治疗的主要方法。虽然针对特定手术的疼痛治疗一直是主要的治疗模式,但有关个性化疼痛治疗的努力正在不断增加。OPI-AID 项目旨在开发围术期疼痛治疗的个性化算法,将人口统计学、手术和麻醉学因素考虑在内。我们将同时进行五项综述,以阐明目前关于围术期阿片类药物治疗个体反应不同方面的证据:纳入英文研究中的成人群体。对以下数据库进行特定综述检索:CENTRAL、MEDLINE、Embase、clinicaltrials.gov 和 clinicaltrial.eu。两位作者将独立筛选引文、提取数据并评估每篇综述(QUIPS、PROBAST 和 RoB2,如相关)的偏倚风险:这些综述将评估围手术期阿片类药物治疗的各个方面,包括个体化治疗策略、特定阿片类药物的选择以及患者的个体反应。这些内容将指导未来围手术期阿片类药物个性化治疗算法(OPI-AID)的开发,该算法将根据标准护理进行临床验证和测试。
{"title":"Opioids and personalized analgesia in the perioperative setting: A protocol for five systematic reviews.","authors":"Anders Peder Højer Karlsen, Pernille Bjersand Sunde, Markus Harboe Olsen, Jens Laigaard, Caroline Folkersen, Trang Xuan Minh Tran, Ida Houtved Rasmussen, Selma Kjartansdóttir, Atena Saito, Michael Asger Andersen, Mathias Maagaard, Nicholas Papadomanolakis-Pakis, Kim Dalhoff, Lone Nikolajsen, Troels Haxholdt Lunn, Christian Sylvest Meyhoff, Janus Christian Jakobsen, Ole Mathiesen","doi":"10.1111/aas.14508","DOIUrl":"10.1111/aas.14508","url":null,"abstract":"<p><strong>Background: </strong>Treatment with opioids is a mainstay in perioperative pain management. While the leading treatment paradigm has been procedure-specific pain management, efforts regarding personalized pain treatment are increasing. The OPI•AID project aims to develop personalized algorithms for perioperative pain management, taking demographic, surgical, and anaesthesiologic factors into account. We will undertake five parallel reviews to illuminate current evidence on different aspects of individual responses to perioperative opioid treatment.</p><p><strong>Methods: </strong>Inclusion of adult populations in English-written studies. Review-specific searches are developed for the following databases: CENTRAL, MEDLINE, Embase, clinicaltrials.gov, and clinicaltrial.eu. Two authors will independently screen citations, extract data, and assess the risks of bias in each review (QUIPS, PROBAST and RoB2, as relevant).</p><p><strong>Conclusion: </strong>These reviews will evaluate various aspects of perioperative opioid treatment, including individualized treatment strategies, selection of specific opioids, and individual patient responses. These will guide future development of a personalized perioperative opioid treatment algorithm (OPI•AID) that will be validated and tested clinically against standard of care.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"1573-1580"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141896442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antibiotic stewardship with multiplex PCR for pneumonia in intensive care patients: A retrospective study. 利用多重 PCR 对重症监护患者肺炎进行抗生素管理:回顾性研究。
IF 1.9 4区 医学 Q2 ANESTHESIOLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-27 DOI: 10.1111/aas.14516
Sine Wichmann, Dorthe Ørsnes Christensen, Claus Antonio Juel Jensen, Jette Bangsborg, Mette Kolpen, Morten Heiberg Bestle

Background: Early initiation of targeted antibiotic therapy is important to achieve the best patient outcomes in intubated patients with pneumonia in the intensive care unit (ICU). This study aimed to investigate the applicability of multiplex polymerase chain reaction (PCR) in an ICU by comparing the test results to the results of conventional microbiological methods to assess the possible impact on antibiotic therapy.

Method: This retrospective study investigated adult patients with pneumonia on mechanical ventilation in the ICU. Tracheal aspirates were collected within 24h after intubation and the initiation of mechanical ventilation. Samples were initially tested by conventional microbiological methods and subsequently re-evaluated with rapid multiplex PCR on stored samples. Concordance between the two methods was assessed. An intensivist and a microbiologist retrospectively reviewed the patients' electronic health records for relevant clinical details to evaluate the potential impact of multiplex PCR results on antibiotic therapy.

Results: In this study, 76 patients were enrolled and 55 (72.4%) tested positive for 95 pathogens using multiplex PCR, while conventional microbiological methods identified 40 pathogens in 32 (42.2%) patients. Concordance between the two methods was observed in 42 (55.3%) patients. Multiplex PCR detected 39 additional pathogens in 31 (40.7%) patients. Retrospective analysis indicated potential antibiotic de-escalation in 35 (46.1%) patients and escalation in 4 (5.3%) patients. Multiplex PCR significantly reduced the turnaround time for test results.

Conclusion: In ICU patients with suspected pneumonia, multiplex PCR identified a higher number of pathogens compared to CMM. A retrospective assessment indicates that the use of multiplex PCR could potentially have prompted the de-escalation of antibiotic therapy in nearly half of the patients. Therefore, multiplex PCR may serve as a supplement to CMM in guiding antibiotic stewardship.

背景:对于重症监护病房(ICU)中的插管肺炎患者来说,尽早开始有针对性的抗生素治疗对于获得最佳疗效非常重要。本研究旨在调查多重聚合酶链反应(PCR)在重症监护病房的适用性,将检测结果与传统微生物学方法的结果进行比较,以评估其对抗生素治疗可能产生的影响:这项回顾性研究调查了在重症监护室接受机械通气的成人肺炎患者。在插管和开始机械通气后的 24 小时内采集气管吸出物。首先用传统微生物学方法对样本进行检测,然后用快速多重 PCR 对保存的样本进行重新评估。对两种方法的一致性进行了评估。一名重症监护医生和一名微生物学家回顾性查看了患者的电子病历,了解相关临床细节,以评估多重 PCR 结果对抗生素治疗的潜在影响:本研究共收录了 76 名患者,其中 55 人(72.4%)使用多重 PCR 检测出 95 种病原体呈阳性,而 32 人(42.2%)使用传统微生物学方法检测出 40 种病原体。有 42 名患者(55.3%)的两种方法检测结果一致。多重 PCR 在 31 例(40.7%)患者中又检测出 39 种病原体。回顾性分析表明,35 例(46.1%)患者可能需要降低抗生素使用剂量,4 例(5.3%)患者需要增加抗生素使用剂量。多重 PCR 大幅缩短了检测结果的周转时间:结论:在 ICU 疑似肺炎患者中,多重 PCR 与 CMM 相比能识别出更多的病原体。回顾性评估表明,使用多重 PCR 有可能促使近一半患者放弃抗生素治疗。因此,在指导抗生素管理方面,多重 PCR 可作为 CMM 的补充。
{"title":"Antibiotic stewardship with multiplex PCR for pneumonia in intensive care patients: A retrospective study.","authors":"Sine Wichmann, Dorthe Ørsnes Christensen, Claus Antonio Juel Jensen, Jette Bangsborg, Mette Kolpen, Morten Heiberg Bestle","doi":"10.1111/aas.14516","DOIUrl":"10.1111/aas.14516","url":null,"abstract":"<p><strong>Background: </strong>Early initiation of targeted antibiotic therapy is important to achieve the best patient outcomes in intubated patients with pneumonia in the intensive care unit (ICU). This study aimed to investigate the applicability of multiplex polymerase chain reaction (PCR) in an ICU by comparing the test results to the results of conventional microbiological methods to assess the possible impact on antibiotic therapy.</p><p><strong>Method: </strong>This retrospective study investigated adult patients with pneumonia on mechanical ventilation in the ICU. Tracheal aspirates were collected within 24h after intubation and the initiation of mechanical ventilation. Samples were initially tested by conventional microbiological methods and subsequently re-evaluated with rapid multiplex PCR on stored samples. Concordance between the two methods was assessed. An intensivist and a microbiologist retrospectively reviewed the patients' electronic health records for relevant clinical details to evaluate the potential impact of multiplex PCR results on antibiotic therapy.</p><p><strong>Results: </strong>In this study, 76 patients were enrolled and 55 (72.4%) tested positive for 95 pathogens using multiplex PCR, while conventional microbiological methods identified 40 pathogens in 32 (42.2%) patients. Concordance between the two methods was observed in 42 (55.3%) patients. Multiplex PCR detected 39 additional pathogens in 31 (40.7%) patients. Retrospective analysis indicated potential antibiotic de-escalation in 35 (46.1%) patients and escalation in 4 (5.3%) patients. Multiplex PCR significantly reduced the turnaround time for test results.</p><p><strong>Conclusion: </strong>In ICU patients with suspected pneumonia, multiplex PCR identified a higher number of pathogens compared to CMM. A retrospective assessment indicates that the use of multiplex PCR could potentially have prompted the de-escalation of antibiotic therapy in nearly half of the patients. Therefore, multiplex PCR may serve as a supplement to CMM in guiding antibiotic stewardship.</p>","PeriodicalId":6909,"journal":{"name":"Acta Anaesthesiologica Scandinavica","volume":" ","pages":"1456-1462"},"PeriodicalIF":1.9,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142078771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Acta Anaesthesiologica Scandinavica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1